Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain.
During the fourth quarter of 1997, a vaccination campaign using the meningococcal C polysaccharide vaccine was carried out in 14 autonomous regions of Spain. The remaining three regions did not participate. In the last quarter of the year 2000, a mass vaccination campaign using the meningococcal C conjugated vaccine was carried out in all regions. In the year 2001 the incidence decreased in all regions, although the decrease was greater in regions that did not vaccinate in 1997. In contrast, case fatality rates did not decrease. During 2001, the incidence rate of meningococcal C disease was still lower (0.32 per 100000 persons-year) in the regions that vaccinated in 1997 with the polysaccharide vaccine than in those that did not (0.64 per 100000 persons-year).
Salleras
L
L
Department of Health and Social Security, Directorate of Public Health, Travessera de les Corts, 131-159 Pavello Ave Maria, Barcelona 08028, Spain. dtorsalut@dsss.scs.es
Domínguez
A
A
Cardeñosa
N
N
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D032541:Mass Vaccination / Q000706:statistics & numerical data*; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000737:chemistry; D038542:Neisseria meningitidis, Serogroup C / Q000276:immunology*; D011134:Polysaccharides / Q000737:chemistry*; D011159:Population Surveillance; D013030:Spain / Q000453:epidemiology; D018074:Vaccines, Conjugate / Q000737:chemistry
D022401:Meningococcal Vaccines; D011134:Polysaccharides; D018074:Vaccines, Conjugate; C410218:serogroup C meningococcal conjugate vaccine